Importance of Tumor Location in Patients With High Preoperative Prostate Specific Antigen Levels (Greater Than 20 ng/ml) Treated With Radical Prostatectomy

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1311-1315

  Magheli, Ahmed ^a,b   Rais Bahrami, Soroush ^a   Peck, Hugh J ^a   Walsh, Patrick C ^a   Epstein, Jonathan I ^a   Trock, Bruce J ^a   Gonzalgo, Mark L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

local; neoplasm recurrence; prostate; prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SEMINAL VESICLE; SURVIVAL RATE; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEMINAL VESICLES; TUMOR MARKERS, BIOLOGICAL;

EID: 34548410450     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.143     Document Type: Article

References (17)

1. Partin A.W., Yoo J., Carter H.B., Pearson J.D., Chan D.W., Epstein J.I., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110
2. Stephenson A.J., Scardino P.T., Eastham J.A., Bianco Jr. F.J., Dotan Z.A., Fearn P.A., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715
3. Gonzalez C.M., Roehl K.A., Antenor J.V., Blunt L.W., Han M., and Catalona W.J. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy. Urology 64 (2004) 723
4. Bastide C., Kuefer R., Loeffler M., de P.R., Gschwend J., and Hautmann R. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml. Prostate Cancer Prostatic Dis 9 (2006) 239
5. Brandli D.W., Koch M.O., Foster R.S., Bihrle R., and Gardner T.A. Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy. BJU Int 92 (2003) 19
6. McNeal J.E. Regional morphology and pathology of the prostate. Am J Clin Pathol 49 (1968) 347
7. Greene D.R., Wheeler T.M., Egawa S., Dunn J.K., and Scardino P.T. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146 (1991) 1069
8. Grignon D.J., and Sakr W.A. Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland?. J Cell Biochem 19 suppl. (1994) 267
9. Van de Voorde W.M., Van Poppel H.P., Verbeken E.K., Oyen R.H., Baert L.V., and Lauweryns J.M. Morphologic and neuroendocrine features of adenocarcinoma arising in the transition zone and in the peripheral zone of the prostate. Mod Pathol 8 (1995) 591
10. Noguchi M., Stamey T.A., Neal J.E., and Yemoto C.E. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 163 (2000) 1751
11. Augustin H., Hammerer P.G., Blonski J., Graefen M., Palisaar J., Daghofer F., et al. Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?. Urology 62 (2003) 79
12. Stamey T.A., Donaldson A.N., Yemoto C.E., McNeal J.E., Sozen S., and Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 160 (1998) 2412
13. Augustin H., Erbersdobler A., Graefen M., Fernandez S., Palisaar J., Huland H., et al. Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones. Prostate 55 (2003) 48
14. Erbersdobler A., Augustin H., Schlomm T., and Henke R.P. Prostate cancers in the transition zone: part 1; pathological aspects. BJU Int 94 (2004) 1221
15. Babaian R.J., Troncoso P., and Ayala A. Transurethral-resection zone prostate cancer detected at cystoprostatectomy. A detailed histologic analysis and clinical implications. Cancer 67 (1991) 1418
16. Pound C.R., Partin A.W., Epstein J.I., and Walsh P.C. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 24 (1997) 395
17. Chun F.K., Briganti A., Jeldres C., Erbersdobler A., Schlomm T., Steuber T., et al. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy. Eur Urol 51 (2006) 949